Thrombolytic agents are used to lyse already formed blood clots in clinical settings where ischemia may be fatal ( acute mycardial infarction, pulmonary embolism, ischemic stroke, and arterial thrombosis). Very precise indications rule the use of these drugs, which are not free from serious side effects ( bleeding). Outline: Mechanism of action of thrombolytic therapy […]
Centocor Ortho Biotech and FDA reminded prescribers of the risk of serious fungal infections associated with TNF-α blockers, this includes the newer Simponi (golimumab).
FDA video warning on gastrointestinal dermatologic and ophthalmic side effects of erlotinib (Tarceva).
The FDA warned prescribers about the risk of serious liver injury associated with the use of the anti-thyroid drug propylthiouracil (PTU). FDA’s warning highlights: There is an increased risk of liver injury with propylthiouracil (PTU) when compared to methimazole. Monitor for symptoms and signs of liver injury when propylthiouracil is chosen as anti-thyroid therapy. This […]
Zolpidem, zoplicone and zaleplon (z-drugs) side effects profile: Australian Prescriber press release
Hypnotic hazards and effects of z-drugs immeasurable “It is difficult to know the extent of use and adverse effects of zolpidem and other z-drugs (zopiclone and zaleplon) because they have never been listed on the Australian Pharmaceutical Benefits Scheme, senior Sleep Disorders Physician Dr Les Olson writes in the latest edition of Australian Prescriber.